Hualan Biological Engineering Inc.

¥12.30As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002007Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (2.42%)
Div yield 3.25%
ROE 4.70%
Biotechnology
Beta (5Y) 0.38
PE TTM 38.24
TSR TTM (20.74%)
Mkt cap ¥22.46B
ROIC 6.59%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥13
4.75%
(57.75%)
Hold 8|0|3|1|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.14
0.14
0.15
0.17
7.51%
2.32%
11.91%
15.08%
Revenue¥B
1.890
1.863
1.900
1.971
15.33%
8.85%
9.66%
8.44%
Peers (US$3.366B)
Cap (US$)
PE
3.756B
35.19x
3.409B
26.88x
Capital
TTM
5Y
10Y
Leveragex
0.232
0.505
0.427
EBIT/Intx
3.381
0.287
0.274
Own earn%
(8.14)
13.53
6.36
Sh yield%
7.12
21.83
18.31
Owners
Insiders/Inst%
6.84
41.51
Short interest%
4.54
SBC / revenue%
1.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
11–16
$1 testx
—
Incr. ROIC%
6